rs72650057

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_001267550.2(TTN):​c.37421T>C​(p.Ile12474Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 16/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00013 ( 0 hom., cov: 12)
Exomes š‘“: 0.00015 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

TTN
NM_001267550.2 missense

Scores

16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1O:1

Conservation

PhyloP100: 1.08

Publications

0 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14793402).
BP6
Variant 2-178659037-A-G is Benign according to our data. Variant chr2-178659037-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 166094.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.37421T>C p.Ile12474Thr missense_variant Exon 182 of 363 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.37421T>C p.Ile12474Thr missense_variant Exon 182 of 363 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.000133
AC:
14
AN:
105270
Hom.:
0
Cov.:
12
show subpopulations
Gnomad AFR
AF:
0.0000678
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000186
Gnomad OTH
AF:
0.000753
GnomAD2 exomes
AF:
0.000131
AC:
7
AN:
53246
AF XY:
0.000114
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000496
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000104
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000146
AC:
119
AN:
814744
Hom.:
0
Cov.:
11
AF XY:
0.000146
AC XY:
60
AN XY:
411654
show subpopulations
āš ļø The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000974
AC:
2
AN:
20526
American (AMR)
AF:
0.000320
AC:
7
AN:
21884
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16466
East Asian (EAS)
AF:
0.0000298
AC:
1
AN:
33578
South Asian (SAS)
AF:
0.0000183
AC:
1
AN:
54708
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45242
Middle Eastern (MID)
AF:
0.00183
AC:
5
AN:
2732
European-Non Finnish (NFE)
AF:
0.000158
AC:
92
AN:
581136
Other (OTH)
AF:
0.000286
AC:
11
AN:
38472
āš ļø The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.313
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000133
AC:
14
AN:
105376
Hom.:
0
Cov.:
12
AF XY:
0.000100
AC XY:
5
AN XY:
49876
show subpopulations
āš ļø The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000676
AC:
2
AN:
29602
American (AMR)
AF:
0.000202
AC:
2
AN:
9884
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2668
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4226
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2988
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5290
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
252
European-Non Finnish (NFE)
AF:
0.000186
AC:
9
AN:
48416
Other (OTH)
AF:
0.000742
AC:
1
AN:
1348
āš ļø The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.0000000000845498), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.311
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000184
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Feb 04, 2023
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 02, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1Other:1
Jan 03, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jan 30, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:not provided
Review Status:no classification provided
Collection Method:clinical testing

- -

TTN-related disorder Uncertain:1
May 22, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The TTN c.37421T>C variant is predicted to result in the amino acid substitution p.Ile12474Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.047% of alleles in individuals of Latino descent in gnomAD. This variant falls within a highly paralogous region. Allele frequency data should be interpreted with caution. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
Dec 27, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
12
DANN
Benign
0.77
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.71
T;T;D
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.15
T;T;T
MetaSVM
Benign
-0.58
T
PhyloP100
1.1
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-1.8
N;.;.
REVEL
Benign
0.12
Sift
Benign
0.33
T;.;.
Polyphen
0.025
.;.;B
Vest4
0.20
MutPred
0.37
.;.;Gain of phosphorylation at I11497 (P = 0.0022);
MVP
0.47
MPC
0.26
ClinPred
0.021
T
GERP RS
4.1
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72650057; hg19: chr2-179523764; API